Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection

被引：0
|
作者：
Hala Mohsen Abdullatif
Rania Ramzi
Engy Adel Mogahed
Carolyne Morcos Ghobrial
Basma Abd El Rasheed Abd El Zaher
Mona S. El Raziky
Hanaa Mostafa El-Karaksy
机构：
[1] Cairo University Pediatric Hospital,Pediatric Hepatology Unit
[2] Kasr Alainy Drug Information Center,undefined
[3] Cairo University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 864
页数：7
相关论文
共 50 条
  • [1] Drug-Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection
    Abdullatif, Hala Mohsen
    Ramzi, Rania
    Mogahed, Engy Adel
    Ghobrial, Carolyne Morcos
    Abd El Rasheed Abd El Zaher, Basma
    El Raziky, Mona S.
    El-Karaksy, Hanaa Mostafa
    CLINICAL DRUG INVESTIGATION, 2019, 39 (09) : 857 - 864
  • [2] Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection
    Fouad, Hanan M.
    Sabry, Magda A.
    Ahmed, Amal
    Hassany, Mohamed
    Al Soda, Mohamed F.
    Aziz, Hossam Abdel
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (03) : 386 - 389
  • [3] Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents
    Quintero, Jesus
    Juamperez, Javier
    Julio, Ecaterina
    Cabello, Vanessa
    Mercadal-Hally, Maria
    Soler-Palacin, Pere
    Segarra, Oscar
    Rodrigo, Carlos
    ANALES DE PEDIATRIA, 2019, 90 (03): : 141 - 147
  • [4] Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
    Yang, Christine Hong Ting
    Goel, Aparna
    Ahmed, Aijaz
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2018, 9 : 103 - 110
  • [5] Effectiveness of sofosbuvir/ledipasvir in hepatitis C virus infection in children and adolescents with malignancy: tertiary center experience
    Ibraheem, Mohammad Fadhil
    Ghali, Hasanein Habeeb
    Kareem, Falah Hasan
    Alqazaz, Ali Duraid
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 8 (04) : 315 - 320
  • [6] Assessment of outcome for sample of Iraqi patients with chronic hepatitis C virus infection treated by Ledipasvir/sofosbuvir drug
    Faraj, Osama Abdulrahman
    AlBayati, Sabeha Moosa
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (12) : S105 - S109
  • [7] Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in children
    Rizza, S. A.
    Nehra, V.
    Temesgen, Z.
    DRUGS OF TODAY, 2017, 53 (08) : 447 - 451
  • [8] Is sofosbuvir/ledipasvir safe for the hearts of children with hepatitis C virus?
    Ghobrial, Carolyne
    Sobhy, Rodina
    Mogahed, Engy
    Abdullatif, Hala
    El-Karaksy, Hanaa
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (02) : 258 - 262
  • [9] The Influence of Treatment with Ledipasvir/Sofosbuvir on Growth Parameters in Children and Adolescents with Chronic Hepatitis C
    Pokorska-Spiewak, Maria
    Dobrzeniecka, Anna
    Marczynska, Magdalena
    VIRUSES-BASEL, 2022, 14 (03):
  • [10] Ledipasvir/Sofosbuvir in the Treatment of Hepatitis C Virus Genotype 6
    Nguyen, Andrew A.
    Weisberg, Ilan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S368 - S368
12345